These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12356550)

  • 1. A doctor talks about: why researchers stopped the Women's Health Initiative study of estrogen and progestin and what this means for you.
    Robb-Nicholson C
    Harv Womens Health Watch; 2002 Sep; 10(1):8. PubMed ID: 12356550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lessons from the Women's Health Initiative (WHI) using hormone replacement therapy with regard to heart disease--the dream that has been broken?].
    Pines A
    Harefuah; 2003 Mar; 142(3):163-5, 240. PubMed ID: 12696464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective.
    Randolph JF;
    Medscape Womens Health; 2002; 7(4):7. PubMed ID: 12466739
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical appraisal of the Women's Health Initiative.
    Speroff L
    J Obstet Gynaecol Res; 2005 Apr; 31(2):80-93. PubMed ID: 15771632
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hold the hormones? The good and the bad about postmenopausal estrogen therapy.
    Nemecek S
    Sci Am; 1997 Sep; 277(3):38, 40. PubMed ID: 9304196
    [No Abstract]   [Full Text] [Related]  

  • 12. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More on the women's health initiative.
    Runowicz CD
    N Engl J Med; 1994 Jun; 330(22):1619-20. PubMed ID: 8177264
    [No Abstract]   [Full Text] [Related]  

  • 16. [The women's health initiative and more].
    Dören M
    Pharm Unserer Zeit; 2004; 33(5):366-71. PubMed ID: 15497331
    [No Abstract]   [Full Text] [Related]  

  • 17. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 18. Oestrogen only arm of women's health initiative trial is stopped.
    Hopkins Tanne J
    BMJ; 2004 Mar; 328(7440):602. PubMed ID: 15016673
    [No Abstract]   [Full Text] [Related]  

  • 19. Declines in breast cancer after the WHI: apparent impact of hormone therapy.
    Clarke CA; Glaser SL
    Cancer Causes Control; 2007 Oct; 18(8):847-52. PubMed ID: 17619153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. By the way, doctor. The "Women's Health Initiative" found that hormone therapy wasn't helpful for avoiding dementia; there was some suggestion that it might even cause cognitive problems. Am I at risk for dementia by continuing hormone therapy?
    Robb-Nicholson C
    Harv Womens Health Watch; 2009 Nov; 17(3):8. PubMed ID: 20069743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.